Crossmark

Microtubule associated serine/threonine kinase-3 inhibits the malignant phenotype of breast cancer by promoting phosphorylation-mediated ubiquitination degradation of yes-associated protein

Crossref DOI link: https://doi.org/10.1186/s13058-025-02028-3

Published Online: 2025-05-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Deng, Ning

Kang, Wei

Du, Jiang

Rong, Xuezhu

Han, Qiang
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (82303490, 82003119)

Fundamental Research Funds for the Central Universities (LD2023026/DUT23YG110)
License Information

Text and Data Mining valid from 2025-05-01

Version of Record valid from 2025-05-01
More Information

Article History

Received: 26 December 2024

Accepted: 17 April 2025

First Online: 1 May 2025

Declarations

:

: This study was approved by the Ethics Committee of Liaoning Cancer Hospital (Approval number: KY20231013) and conducted in accordance with the principles of the Declaration of Helsinki. All patients with breast cancer who participated in this study signed an informed consent form. Animal assays were performed according to the Animal Ethics Committee (IACUC) guidelines issued by China Medical University.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below